Valuation check: XLRM's profit margin is -76.45%, below the sector sector average of 13.09%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2021
Trailing 12 months ending Mar 2021
The latest profit margin for XLRM is -76.45% as of March 2021. That is below the sector sector average of 13.09%. Investors often review this figure alongside XLR Medical's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, XLRM currently prints -76.45% for profit margin, while the sector average sits near 13.09%. That is roughly 684.1% below the sector mean. Large gaps often invite a closer look at XLR Medical's growth, margins, and balance sheet.
Profit Margin shows how effectively XLR Medical converts resources into returns. At -76.45%, XLRM may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting XLRM's profit margin (-76.45%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.